Metformin has been prescribed for over 60 years and is the most widely used diabetes medication in the world. Yet persistent myths cause many patients to refuse it, take it inconsistently, or stop without telling their doctor. Here's what the evidence actually shows.
💊 Bottom line: Metformin is the safest, most studied first-line medication for Type 2 diabetes. The American Diabetes Association recommends it as initial therapy for most patients.
Myth #1: "Metformin is hard on the kidneys"
Fact: Metformin does not damage the kidneys. It is cleared by the kidneys, which means it can accumulate if kidney function is severely reduced — which is why it's dose-adjusted or paused in advanced CKD. But in people with normal to mildly reduced kidney function (eGFR ≥30–45), metformin is safe. Updated 2016 FDA guidelines actually expanded its use to include moderate CKD, reversing the older overly-cautious labeling.
Myth #2: "Metformin causes lactic acidosis"
Fact: Lactic acidosis is extremely rare with metformin — estimated at fewer than 10 cases per 100,000 patient-years. It primarily occurs in people with serious contraindications (severe kidney disease, liver failure, heart failure, or excessive alcohol use). In otherwise appropriate candidates, the risk is negligible. Metformin's overall safety profile is excellent.
Myth #3: "Metformin causes low blood sugar"
Fact: Metformin does not cause hypoglycemia (low blood sugar) when used alone. It works by reducing glucose production in the liver and improving insulin sensitivity — not by stimulating insulin secretion. This makes it uniquely safe in this regard. Hypoglycemia only becomes a risk if metformin is combined with insulin or a sulfonylurea.
Myth #4: "Metformin causes weight gain"
Fact: The opposite is true. Metformin is weight-neutral to mildly weight-reducing. Unlike sulfonylureas or insulin, it does not promote fat storage. Some research suggests modest weight loss benefits, which is one reason it's preferred in overweight patients with T2D.
Myth #5: "The GI side effects are unbearable"
Fact: GI symptoms — nausea, diarrhea, stomach upset — are the most common side effects, affecting 20–30% of patients at initiation. However, most side effects are temporary, dose-related, and can be minimized by:
- Starting at a low dose and titrating gradually
- Taking metformin with food
- Switching to extended-release (ER) formulation, which has significantly fewer GI effects
For most patients, GI symptoms resolve within 2–4 weeks.
Myth #6: "Metformin depletes B12 — it's dangerous"
Fact: Metformin does reduce B12 absorption over time in about 6–10% of long-term users, and this can occasionally lead to B12 deficiency. This is real, but manageable. Annual B12 monitoring is recommended for patients on metformin long-term. If deficiency occurs, supplementation resolves it. This is a minor, monitorable effect — not a reason to avoid an otherwise effective medication.
Myth #7: "There are better newer drugs — metformin is outdated"
Fact: Newer drug classes like GLP-1 agonists and SGLT2 inhibitors have important cardiovascular and kidney benefits and are excellent additions to therapy. But metformin remains the foundation because: it's highly effective, extremely affordable, has decades of safety data, and is well-tolerated by most patients. The newer agents are increasingly used alongside or instead of metformin in specific situations — they're complementary, not replacements across the board.
Key Takeaways
- Metformin does not damage kidneys at appropriate doses — it's dose-adjusted, not avoided, in CKD
- Lactic acidosis is extremely rare in appropriate candidates
- Metformin does not cause low blood sugar when used alone
- GI side effects are common but usually temporary — extended-release formulation helps significantly
- Monitor B12 annually with long-term use
- Metformin remains the gold standard first-line diabetes medication
Our Team Can Help with Your Medications
All five of our providers prescribe and manage endocrine medications. Book with any member of our team:
Book an Appointment → or call 832-968-7003